Management of Invasive Fungal Disease in Neonates and Children

Area of Science:

• Pediatric Infectious Diseases
• Mycology
• Clinical Pharmacy

Background:

• Invasive fungal diseases (IFD) significantly contribute to morbidity and mortality in vulnerable pediatric populations, including premature neonates and immunocompromised children.
• Current diagnostic and therapeutic strategies for IFD in these patients are complex and present ongoing management challenges.

Purpose of the Study:

• To investigate and understand the current practices in managing IFD among neonates and children across major UK pediatric centers.
• To identify variations in diagnostic tool utilization, imaging, and antifungal treatment protocols.

Main Methods:

• A nationwide survey was conducted involving 13 of the largest pediatric tertiary teaching centers in the United Kingdom.
• Data collected focused on diagnostic methods, imaging modalities, antifungal prophylaxis, empirical treatment, and first-line therapies for common IFDs like candidemia and invasive aspergillosis.

Main Results:

• Significant variability was observed in the use of fungal diagnostic tools and imaging across surveyed centers.
• Antifungal prophylaxis was common for extremely low birth weight infants and high-risk hematology-oncology patients, but with diverse drug choices.
• Empirical treatment was favored for febrile neutropenia, with specific first-line agents identified for candidemia and invasive aspergillosis; combination therapy was often used for disseminated aspergillosis.

Conclusions:

• The survey underscores the need for standardized approaches and further pediatric clinical trials to address knowledge gaps in IFD management.
• Optimizing the care of neonates and children with IFD requires focused attention on refining diagnostic and therapeutic strategies based on evidence.